文献速递脊髓损伤康复

脊髓损伤患者阿片类药物使用率:基于州处方药监测数据的估计

Opioid Use Among Individuals With Spinal Cord Injury: Prevalence Estimates Based on State Prescription Drug Monitoring Program Data.
PubMed 文献 · Arch Phys Med Rehabil · 2020-11-20

该队列研究链接南卡罗来纳州SCI登记系统与州处方药监测数据,纳入503例慢性(>1年)SCI患者(2013—2014年受伤,伤后存活≥3年),分析伤后第13—36个月阿片处方填充情况。结果显示53.5%的患者至少填充1次阿片处方,23%存在高风险填充(日均MME>50),38%同时使用苯二氮䓬类、镇静剂或催眠药。

要点

  • 慢性SCI患者中53.5%在伤后第2—3年至少填充1次阿片处方。
  • 填充阿片处方者中23%日均MME>50,38%合并苯二氮䓬类/镇静剂/催眠药处方。
  • 需监测阿片使用并减少高风险合并用药以降低不良结局风险。

核心结论

  • 慢性SCI患者阿片使用率较高,超过一般人群观察到的水平。
  • 高风险填充(日均MME>50)及合并苯二氮䓬类/镇静剂/催眠药处方的比例值得关注。

研究设计与样本

  • 队列研究,链接南卡罗来纳州SCI登记系统与州处方药监测项目两个全州范围人群数据库。
  • 纳入503例慢性(>1年)SCI患者,受伤时间为2013—2014年,伤后存活至少3年。

主要发现

  • 53.5%(269例)在伤后第2年或第3年至少填充1次阿片处方,2年研究期间共3386次阿片处方填充。
  • 平均阿片处方天数为293±367天,平均覆盖期为389±290天,覆盖期内平均日MME为41±70。
  • 填充阿片处方者中23%存在高风险填充(>50 MME),38%同时有苯二氮䓬类、镇静剂或催眠药处方。

关键数值与推荐

  • 高风险填充定义为日均MME>50。
  • 结局指标包括2年期间阿片处方总天数、覆盖期长度、覆盖期内平均日MME及阿片与苯二氮䓬类/镇静剂/催眠药同时覆盖天数。

临床怎么用

  • 提供者应评估和监测SCI患者的阿片使用情况。
  • 减少同时使用高风险药物(如阿片与苯二氮䓬类/镇静剂/催眠药)以降低不良结局风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the prevalence of opioid use in individuals with chronic spinal cord injury (SCI) living in South Carolina. DESIGN: Cohort study. SETTING: Data from 2 statewide population-based databases, an SCI Registry and the state prescription drug monitoring program, were linked and analyzed. PARTICIPANTS: The study included individuals (N=503) with chronic (>1y) SCI who were injured between 2013 and 2014 in South Carolina and who survived at least 3 years postinjury. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Filled opioid prescriptions over a 2-year period (months 13-36 after injury). The main outcomes were total number of days with an opioid prescription over the 2-year period, length of coverage period [(final day of prescription coverage+the days supplied)-first day of prescription coverage], average daily morphine milligram equivalents (MME) over the coverage period, and concurrent days covered by an opioid and a prescription for benzodiazepines, sedatives, or hypnotics. RESULTS: A total of 53.5% of the cohort (269 individuals) filled at least 1 opioid prescription during their second or third year after SCI. In total, there were 3386 opioid fills during the 2-year study. On average, the total number of opioid prescription days was 293±367. The average coverage period was 389±290 days, and the average daily MME during the coverage period was 41±70 MME. Of those who filled an opioid prescription, 23% had high-risk fills (>50 MME), and 38% had concurrent prescriptions for benzodiazepines, sedatives, or hypnotics. CONCLUSIONS: The prevalence of opioid use was high among individuals with chronic SCI, exceeding rates observed in the general population. Also concerning were the rates of high-risk fills, based on average daily MME and concurrent benzodiazepine, sedative, or hypnotic prescriptions. These findings, taken together with those of earlier studies, should be used by providers to assess and monitor opioid use, decrease concurrent high-risk medication use, and attenuate the risk of adverse outcomes.

来源:Arch Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. DiPiro ND, Murday D, Corley EH, et al. Opioid Use Among Individuals With Spinal Cord Injury: Prevalence Estimates Based on State Prescription Drug Monitoring Program Data. Arch Phys Med Rehabil. 2020. PMID: 33227268. doi:10.1016/j.apmr.2020.10.128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。